Pengaruh Dukungan Keluarga Terhadap Efektivitas Terapi Penyakit Crohn
DOI:
https://doi.org/10.59680/anestesi.v2i4.1425Keywords:
family support, therapy effectiveness, Crohn’s diseaseAbstract
This study examines the impact of family support on the effectiveness of Crohn's disease therapy through a meta-analysis of 18 studies involving 5,876 patients. The analysis reveals a significant positive effect (Hedges' g = 0.58, 95% CI [0.42, 0.74], p < .001) of family support on various therapeutic outcomes. The strongest effect was observed in the dimensions of quality of life (g = 0.67, 95% CI [0.48, 0.86]) and clinical remission (OR = 2.14, 95% CI [1.68, 2.73]). Furthermore, emotional support was found to have the largest effect (g = 0.63, 95% CI [0.45, 0.81]) compared to other types of family support. Mediation analysis indicated that medication adherence (indirect effect = 0.15, 95% CI [0.08, 0.22]), stress reduction (0.12, 95% CI [0.05, 0.19]), and increased self-efficacy (0.09, 95% CI [0.03, 0.15]) were significant mediators in the relationship between family support and Crohn's disease treatment efficacy. Additionally, a stronger effect of family support was observed in patients with more severe disease (Q = 4.82, p = .028) and samples with a higher proportion of females (? = 0.012, p = .03). These findings extend the work of Sewitch et al. (2001) and Moradkhani et al. (2013) by providing a more precise quantification of the effects of family support and identifying several key moderators. Unlike Trindade et al. (2017), this study consistently found a positive effect of family support on Crohn's disease therapy. The novelty of this research lies in identifying specific mechanisms and moderating factors affecting the relationship between family support and therapy effectiveness, offering a deeper understanding of the complex role of family support in Crohn's disease management.
References
Baumgart, D. C., & Sandborn, W. J. (2012). Crohn's disease. The Lancet, 380(9853), 1590-1605.
Cohen, S. (2004). Social relationships and health. American Psychologist, 59(8), 676–684.
Cohen, S., & Wills, T. A. (1985). Stress, social support, and the buffering hypothesis. Psychological Bulletin, 98(2), 310-357.
DiMatteo, M. R. (2004). Social support and patient adherence to medical treatment: a meta-analysis. Health Psychology, 23(2), 207-218.
Drossman, D. A. (2016). Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology, 150(6), 1262-1279.
Engel, G. L. (1977). The need for a new medical model: a challenge for biomedicine. Science, 196(4286), 129–136.
Gajendran, M., Loganathan, P., Catinella, A. P., & Hashash, J. G. (2018). A comprehensive review and update on Crohn's disease. Disease-a-Month, 64(2), 20–57.
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009). Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflammatory Bowel Diseases, 15(7), 1105-1118.
Higgins, J. P., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (Eds.). (2019). Cochrane handbook for systematic reviews of interventions. John Wiley & Sons.
Martire, L. M., & Helgeson, V. S. (2017). Close relationships and the management of chronic illness: Associations and interventions. American Psychologist, 72(6), 601–612.
Mayberry, L. S., & Osborn, C. Y. (2012). Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care, 35(6), 1239–1245.
Moradkhani, A., Beckman, L. J., & Tabibian, J. H. (2013). Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors. Journal of Crohn's and Colitis, 7(6), 467–473.
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., ... & Kaplan, G. G. (2017). Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet, 390(10114), 2769–2778.
Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., ... & Colombel, J. F. (2015). Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. American Journal of Gastroenterology, 110(9), 1324-1338.
Sewitch, M. J., Abrahamowicz, M., Bitton, A., Daly, D., Wild, G. E., Cohen, A., ... & Dobkin, P. L. (2001). Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. American Journal of Gastroenterology, 96(5), 1470-1479.
Taylor, S. E. (2011). Social support: A review. In H. S. Friedman (Ed.), The Oxford Handbook of Health Psychology (pp. 189–214). Oxford University Press.
Trindade, I. A., Ferreira, C., & Pinto-Gouveia, J. (2017). The longitudinal effects of emotion regulation on physical and psychological health: A latent growth analysis exploring the role of cognitive fusion in inflammatory bowel disease. British Journal of Health Psychology, 22(3), 642-660.
Uchino, B. N. (2006). Social support and health: a review of physiological processes potentially underlying links to disease outcomes. Journal of Behavioral Medicine, 29(4), 377-387.
Zhang, M., Hong, L., Zhang, T., Lin, Y., Zheng, S., Zhou, X., ... & Zhong, J. (2016). Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn's disease. Patient Preference and Adherence, 10, 2387–2396.
